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Abstract
Introduction: Antisense oligonucleotides (ASOs) are short chemically modified
oligonucleotides (5-7.4 kDa) that can produce a pharmacological effect by binding to RNA
and affecting intermediary metabolism. Over 35 phosphorothioate (PS) ASOs are at
various stages of clinical development for use as therapeutic agents and pharmacological
tools. Antisense therapy is a progressing area of research, as these small strands of
nucleotide oligomers can be produced to silence genes that aggravate chronic disorders or
infections. An important distinction for ASOs compared to DNA is the substitution of the
phosphodiester (PO) backbone with the PS modification. This sulfur substitution allows for
these polar polyanionic molecules to have high stability in biological fluids and selective
binding to cell surfaces. Although there is a premium for clinical development of these short
chain molecules, the current understanding of the pathways for their ability to traverse
plasma membranes remains unresolved. Injected gymnotic ASOs have been shown to
accumulate in the liver via the organ’s functional scavenging mechanism in highly
endocytically active sinusoidal endothelial cells (SECs) and Kupffer cells (KC) compared to
hepatocytes. Our work outlines how a non-DNA binding class of scavenger receptors
known as Stabilins binds to, and internalizes these small PS ASOs. Methods: Primary
cells from rat and mouse were isolated and cultured with 125I-ASOs. Stable cell lines
expressing Stabilin-1 and two Stabilin-2 isoforms (315-HARE and 190-HARE), were used
to analyze binding affinity, endocytosis and degradation of 125I-ASOs in the cell. Colocalization was also done to analyze trafficking of ASOs once internalized within the cell
by use of fluorescent ASO and lysotracker. Results: It was determined that PS ASOs bind
with high affinity to the Stabilin class receptors with the majority of internalization performed
by clathrin-mediated endocytosis. Binding was determined to be dependent on proper
folding of the receptor, along with relying on salt-bridge formation. Once inside the cell via
the Stabilin receptors, co-localization analysis showed ASOs being trafficked for
degradation in the lysosome. Increased internalization rates of an ASO targeting the noncoding RNA of malat-1, in the Stabilin-expressing cell lines reduced malat-1 expression
more efficiently, indicating not all ASOs are trafficked to the lysosome after internalization.
Conclusion: Our work shows that ASOs are internalized into the cells of the liver through
clathrin-mediated endocytosis. The understanding of the pathway(s) for chemically
modified ASO internalization and trafficking with cell surface receptors will aid in future
clinical design of ASOs as therapeutic agents.

A.

A.

B.

C.

D.

B.

C.

D.

Fig. 9: Endocytosis with Drug Inhibitors.
Fig. 3: Half-life and tissue distribution in mice.

A)
Intravascular injections in mice with 1.0 mg/kg 125I-ASO resulted
in a half-life of 9 min in the blood. B) Approximately 20% of all
ASO was contained in the liver. C) Within the liver, over 80% of
the ASO was in the non-parenchymal fraction and D) the highest
distribution of ASO was in the LSECs.
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Fig. 6: Endocytosis with competition.

All four cell lines were incubated with 0.1 mM
125I-ASO in the presence of 20 mM
competitor as indicated for up to 90 min.
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Endocytosis of 0.1 µM 125I-ASO in EV (A), Stabilin-1 (B), 315-HARE (C),
and 190-HARE (D) cell lines at one time point (90 mins) as either
untreated control (black bars) or with drug/conditions (grey bars) that
inhibit clathrin-mediated endocytosis.Dimethyl sulfoxide solvent control,
P- 30.0 µM PitStop2, Dy-300 µM-Dynasore, Su-0.4 M sucrose.
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Introduction: Stabilin receptors

Fig. 10: Degradation of ASO in cells.
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D.

A) 190-HARE and B) rat LSECs were incubated with 0.1 mM 125I-ASO
with 20 mM the indicated competitors for 90 min showing similar
uptake values.

Fig. 1:

The Stabilin receptors. Stab1 and Stab2 are expressed in endothelium of liver,
lymph node, spleen and bone marrow. Both receptors are comprised of the same domain
organization, although Stab1 does not have a functional LINK domain and cannot be categorized
as a hyalectin. Both receptors bind to heparin, GDF-15, phosphatidylserine, advanced glycation
end-products (AGE), and modified LDL. Individually, Stab1 binds to lactogen and SPARC and
Stab2 binds with HA, CS, and collagen pro-peptides. Neither receptor binds natural DNA or RNA
with phosphodiester backbones. Both receptors undergo proteolytic cleavage/maturation with
Stab1 expressed as isomers of nearly the same size in a 1:1 ratio and Stab2 expressed as 315and 190-kDa receptors in a 5:1 to 2:1 ratio depending on the tissue.
= EGF domain,
=
Fas-1 domain,
= transmembrane domain,
= Link domain

A.

A.

Fig. 4:

Stabilin receptor internalize ASOs. A) Cell lysates on
5% SDS-PAGE from HEK Flp-In 293 cells expressing parent pcDNA5
(empty vector (EV)) (lane 1), Stabilin-1 (lane 2), Stabilin-2, 315-HARE
(lane 3, black arrowhead), or Stabilin-2, 190-HARE (lane 4, open
arrowhead) were probed with anti-V5 to visualize recombinant protein
expression and anti-vinculin as load control (black arrow). B) All four
cell lines were subject to 0.1 mM 125I-ASO over 9 hrs. C) At least half of
the internalization is regulated by clathrin-mediated endocytosis (gray
bars) in contrast to untreated controls (black bars). D) A small
increase in binding occurs with the 190-HARE cells and not with the
other cell lines when compared with EV indicating that Stabilin
receptors are primarily involved with endocytosis of ASO from the cell
surface. NS = not significantly different from control. * is p=0.038.
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Fig. 2:

Fig. 7: Competition in both 190-HARE and rat primary LSECs.
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EV, 190-HARE and 315HARE cells were incubated with 0.1 mM 125I-ASO for 2 hrs (pulse),
washed with PBS, and incubated in fresh medium for 6 additional hrs
(chase). The chase medium was subject to DEAE column
chromatography to capture the ASO. Degraded and partially degraded
ASO was eluted with 0.4 M NaCl and intact ASO was eluted with 2.0 M
NaCl. A) The ratio of degraded to intact ASO was highest in the Stab2
expressing cell lines in contrast to the EV. B) Left: 125I-ASO was
assessed for intrisic degradation in the prepartion indicated that at least
80% was intact (black bars). Mice were injected with 1.0 mg/kg 125IASO and urine was collected over a 2 hr period resulting in the majority
of ASO in urine is degraded.
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Fig. 11:

Efficient gene expression knockdown in Stabilinexpressing cells. All four cell lines were incubated with 0.001-100
mM ASO against malat-1, a long non-coding RNA, for A) 24 or B) 48
hrs and assessed for malat-1 expression levels by qPCR.
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Conclusions
Components of ASOs

Fig. 8:
Fig. 5: Binding characteristics of ASO and 190-HARE.

A) Purified
190-HARE or BSA was plated in polysorp wells and incubated with
increasing concentrations of 125I-ASO. B) 0.05 mM 125I-ASO was incubated
with increasing concentrations of NaCl to disrupt ionic bonding, urea to
disrupt hydrogen bonding, or guanidinium chloride to disrupt protein folding.

Funding Sources:
Table. 1:

ASO polymers used in this study.

Stabilin receptors traffick ASO to lysosomes. A) EV and 190HARE cells were incubated with 0.05 mM Cy3-ASO (red) for 1, 3, or 6 hrs and
then incubated with 1.0 mM Lysotracker (green) for 25 min. and imaged by
confocal microscopy. Images were processed with Fiji Coloc-2 software and the
colocalization data was quantified in B.
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• Liver is a primary site for ASO
sequestration from blood.
• Stabilin-1 and both Stabilin-2 receptors
increased internalization of ASOs from the
cell surface.
• ASOs bind Stabilins via ionic bonding
• ASOs composed of phophorothioate
linkages and methoxyethyl modifications
have higher affinities for the Stabilins than
the morpholinos or phosphodiester ASOs.
• Internalization by the Stabilin receptors
increases lysosome delivery which is a
dead-end for ASOs, but receptor
internalization also enhances gene knockdown.

